Supportive Care for High Cholesterol
(ALLTOP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the supportive care treatment for high cholesterol safe for humans?
The research articles reviewed do not provide specific safety data for supportive care treatment for high cholesterol. However, they highlight the importance of monitoring adverse events (unwanted side effects) in general, especially with dietary supplements and medications, to ensure safety in healthcare settings.12345
How does this treatment for high cholesterol differ from other treatments?
What data supports the effectiveness of the treatment Supportive care for high cholesterol?
Research shows that educational and behavioral strategies, which are part of supportive care, can help manage high cholesterol by encouraging lifestyle changes and adherence to treatment plans. Nurse-centered programs that support lifestyle and medical therapies have been successful in helping patients achieve cholesterol goals.6791112
Who Is on the Research Team?
Robert D Fishberg, MD
Principal Investigator
Atlantic Health System
Are You a Good Fit for This Trial?
This trial is for individuals with high cholesterol or related lipid disorders. It's aimed at those who could benefit from improved treatment access both at their primary care and specialty levels. The goal is to identify high-risk patients using electronic health records and work closely with their primary doctors for better management.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive comprehensive medical management to reduce LDL-C levels
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Supportive care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Atlantic Health System
Lead Sponsor
Regeneron Pharmaceuticals
Industry Sponsor
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer since 1988
MD and PhD in Medicine
George Yancopoulos
Regeneron Pharmaceuticals
Chief Medical Officer since 1997
MD from Harvard Medical School